These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15000615)

  • 21. Dose calculation formalisms and consensus dosimetry parameters for intravascular brachytherapy dosimetry: recommendations of the AAPM Therapy Physics Committee Task Group No. 149.
    Chiu-Tsao ST; Schaart DR; Soares CG; Nath R;
    Med Phys; 2007 Nov; 34(11):4126-57. PubMed ID: 18072478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monte Carlo and thermoluminescence dosimetry of the new IsoSeed model I25.S17 125I interstitial brachytherapy seed.
    Lymperopoulou G; Papagiannis P; Sakelliou L; Karaiskos P; Sandilos P; Przykutta A; Baltas D
    Med Phys; 2005 Nov; 32(11):3313-7. PubMed ID: 16370418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A BrachyPhantom for verification of dose calculation of HDR brachytherapy planning system.
    Austerlitz C; Campos CA
    Med Phys; 2013 Nov; 40(11):112103. PubMed ID: 24320456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monte carlo investigation of the dosimetric properties of the new 103Pd BrachySeedPd-103 Model Pd-1 source.
    Chan GH; Prestwich WV
    Med Phys; 2002 Sep; 29(9):1984-90. PubMed ID: 12349919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose rate table for a 32P intravascular brachytherapy source from Monte Carlo calculations.
    Bohm TD; Mourtada FA; Das RK
    Med Phys; 2001 Aug; 28(8):1770-5. PubMed ID: 11548948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monte Carlo dosimetry of the
    Wu J; Kang S; Wang P; Li J; Wang X
    Radiat Oncol; 2023 Jan; 18(1):13. PubMed ID: 36670476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dosimetry characterization of a 32P source wire used for intravascular brachytherapy with automated stepping.
    Mourtada F; Soares CG; Seltzer SM; Bergstrom PM; Fernández-Verea JM; Asenjo J; Lott SH
    Med Phys; 2003 May; 30(5):959-71. PubMed ID: 12773005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monte Carlo dosimetry of the selectSeed 125I interstitial brachytherapy seed.
    Karaiskos P; Papagiannis P; Sakelliou L; Anagnostopoulos G; Baltas D
    Med Phys; 2001 Aug; 28(8):1753-60. PubMed ID: 11548946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dosimetric characteristics of the Pharma Seed model BT-125-I source.
    Popescu CC; Wise J; Sowards K; Meigooni AS; Ibbott GS
    Med Phys; 2000 Sep; 27(9):2174-81. PubMed ID: 11011748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monte Carlo and experimental characterization of the first AMIRS 103Pd brachytherapy source.
    Raisali G; Ghonchehnazi MG; Shokrani P; Sadeghi M
    Appl Radiat Isot; 2008 Dec; 66(12):1856-60. PubMed ID: 18657981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.
    Rivard MJ; Coursey BM; DeWerd LA; Hanson WF; Huq MS; Ibbott GS; Mitch MG; Nath R; Williamson JF
    Med Phys; 2004 Mar; 31(3):633-74. PubMed ID: 15070264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of encapsulated 170Tm sources for their potential use in brachytherapy.
    Ballester F; Granero D; Perez-Calatayud J; Venselaar JL; Rivard MJ
    Med Phys; 2010 Apr; 37(4):1629-37. PubMed ID: 20443484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monte Carlo and experimental dosimetry of an 1251 brachytherapy seed.
    Dolan J; Lia Z; Williamson JF
    Med Phys; 2006 Dec; 33(12):4675-84. PubMed ID: 17278820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A segmented 32P source Monte Carlo model to derive AAPM TG-60 dosimetric parameters used for intravascular brachytherapy.
    Mourtada F; Soares CG; Horton JL
    Med Phys; 2004 Mar; 31(3):602-8. PubMed ID: 15070260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dosimetric characterization of model Cs-1 Rev2 cesium-131 brachytherapy source in water phantoms and human tissues with MCNP5 Monte Carlo simulation.
    Wang J; Zhang H
    Med Phys; 2008 Apr; 35(4):1571-9. PubMed ID: 18491551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sub-second high dose rate brachytherapy Monte Carlo dose calculations with bGPUMCD.
    Hissoiny S; D'Amours M; Ozell B; Despres P; Beaulieu L
    Med Phys; 2012 Jul; 39(7):4559-67. PubMed ID: 22830787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dosimetric properties of the new 125I BrachySeed model LS-1 source.
    Chan GH; Prestwich WV
    Med Phys; 2002 Feb; 29(2):190-200. PubMed ID: 11865990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A simple modification of TG-43 based brachytherapy dosimetry with improved fitting functions: application to the selectSeed source.
    Juan-Senabre XJ; Porras I; Lallena AM
    Phys Med; 2013 Jun; 29(4):403-11. PubMed ID: 22698855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monte Carlo dosimetric characterization of the Cs-137 selectron/LDR source: evaluation of applicator attenuation and superposition approximation effects.
    Pérez-Calatayud J; Granero D; Ballester F; Puchades V; Casal E
    Med Phys; 2004 Mar; 31(3):493-9. PubMed ID: 15070245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monte Carlo calculation of dosimetry parameters for the IR08-103Pd brachytherapy source.
    Saidi P; Sadeghi M; Shirazi A; Tenreiro C
    Med Phys; 2010 Jun; 37(6):2509-15. PubMed ID: 20632562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.